Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mélanie Dupont

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Soins. Pediatrie, Puericulture|October 26, 2024
[Spotting the unthinkable. Tips for detecting incest]Mélanie Dupont
FEBS Letters|December 3, 2014
Molecular exploration of the α(1A)-adrenoceptor orthosteric site: binding site definition for epinephrine, HEAT and prazosinArhamatoulaye Maïga, Mélanie Dupont, Guillaume Blanchet, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case ReportAnne Godier, Mélanie Dupont, Jean-Philippe Desilles, et al.
Leukemia Research|December 29, 2020
Synergy of FLT3 inhibitors and the small molecule inhibitor of LIM kinase1/2 CEL_Amide in FLT3-ITD mutated Acute Myeloblastic Leukemia (AML) cellsHanane Djamai, Jeannig Berrou, Mélanie Dupont, et al.
Oncotarget|May 21, 2015
BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cellsMarie-Magdelaine Coudé, Thorsten Braun, Jeannig Berrou, et al.
Journal of Clinical Medicine|November 26, 2022
Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (<i>BCR::ABL+</i>) Acute Lymphoblastic Leukemia (ALL)Jeannig Berrou, Mélanie Dupont, Hanane Djamai, et al.
Biomedicines|November 27, 2021
Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML)Hanane Djamai, Jeannig Berrou, Mélanie Dupont, et al.
Anaesthesia, Critical Care & Pain Medicine|May 23, 2025
Pain intensity after robotic-assisted urological surgery: the PAIROU study an international prospective cohort studyPauline Rouxel, Emilien Rayon, Anne-Sophie Bellocq, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Soins. Pediatrie, Puericulture|October 26, 2024
[Spotting the unthinkable. Tips for detecting incest]Mélanie Dupont
FEBS Letters|December 3, 2014
Molecular exploration of the α(1A)-adrenoceptor orthosteric site: binding site definition for epinephrine, HEAT and prazosinArhamatoulaye Maïga, Mélanie Dupont, Guillaume Blanchet, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case ReportAnne Godier, Mélanie Dupont, Jean-Philippe Desilles, et al.
Leukemia Research|December 29, 2020
Synergy of FLT3 inhibitors and the small molecule inhibitor of LIM kinase1/2 CEL_Amide in FLT3-ITD mutated Acute Myeloblastic Leukemia (AML) cellsHanane Djamai, Jeannig Berrou, Mélanie Dupont, et al.
Oncotarget|May 21, 2015
BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cellsMarie-Magdelaine Coudé, Thorsten Braun, Jeannig Berrou, et al.
Journal of Clinical Medicine|November 26, 2022
Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (<i>BCR::ABL+</i>) Acute Lymphoblastic Leukemia (ALL)Jeannig Berrou, Mélanie Dupont, Hanane Djamai, et al.
Biomedicines|November 27, 2021
Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML)Hanane Djamai, Jeannig Berrou, Mélanie Dupont, et al.
Anaesthesia, Critical Care & Pain Medicine|May 23, 2025
Pain intensity after robotic-assisted urological surgery: the PAIROU study an international prospective cohort studyPauline Rouxel, Emilien Rayon, Anne-Sophie Bellocq, et al.
Pageof 1